Erste Group Bank Weighs in on Sandoz Group FY2026 Earnings

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY) – Investment analysts at Erste Group Bank dropped their FY2026 earnings per share estimates for shares of Sandoz Group in a research report issued to clients and investors on Wednesday, October 21st. Erste Group Bank analyst H. Engel now forecasts that the company will post earnings of $4.17 per share for the year, down from their prior forecast of $4.22. Erste Group Bank currently has a “Strong-Buy” rating on the stock. The consensus estimate for Sandoz Group’s current full-year earnings is $4.15 per share.

Sandoz Group Price Performance

SDZNY stock opened at $99.36 on Wednesday. The stock’s fifty day simple moving average is $87.28 and its two-hundred day simple moving average is $83.75. Sandoz Group has a 1-year low of $62.26 and a 1-year high of $100.34.

Sandoz Group Company Profile

Sandoz Group AG is a Switzerland-based pharmaceutical company focused on generic and biosimilar medicines. Its portfolio includes prescription medicines across therapeutic areas such as anti-infectives, immunology, oncology, ophthalmology, respiratory care and cardiovascular treatments. The company also supplies complex generics, including injectable, inhaled and other specialty formulations.

Sandoz serves patients and healthcare providers through a broad international commercial and manufacturing network, with operations and products spanning Europe, North America, Asia and other global markets.